This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (25)  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Topic Collections  • Neurology  • Neurocutaneous Diseases  • Dermatologic Disorders  • Dermatologic Disorders, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

A Prospective Study of Vascular and Neurophysiologic Studies in Erythromelalgia

Mark D. P. Davis, MD; Paola Sandroni, MD, PhD; Thom W. Rooke, MD; Phillip A. Low, MD

Arch Dermatol. 2003;139:1337-1343.

Objective  To assess the frequency and type of vascular changes and neurologic abnormalities in patients with erythromelalgia.

Design  Prospective study of patients with no spontaneous symptoms at the time of their visit and with provoked symptoms.

Setting  Tertiary referral center.

Patients  Sixty-seven patients presenting with erythromelalgia at Mayo Clinic, Rochester, Minn, from 1999 through 2001.

Interventions  Testing nerve and vascular function in patients without symptoms present; testing vascular function after provoking symptoms with exercise or by increasing ambient temperature.

Main Outcome Measures  In patients in whom symptoms could be elicited, vascular function with and without symptoms was assessed by measurement of local skin temperature, laser Doppler flow, and transcutaneous oximetry. Neurologic assessment included electromyography, nerve conduction studies, and autonomic reflex screening (using the quantitative sudomotor axon reflex test, adrenergic function testing, heart rate response to deep breathing, and the Valsalva ratio).

Results  Autonomic reflex screening was performed on 57 (85%) of the 67 patients. Of these 57 patients, 46 (81%) had abnormal quantitative sudomotor axon reflex test results; 14 (25%) had abnormal adrenergic function; and 15 (26%) had abnormal cardiovagal function. Put in another way, results were abnormal for 49 (86%) of the 57 patients who had autonomic reflex screening. Severe sudomotor abnormalities (ie, absent or markedly reduced sweat production) were present in 46 (94%) of these 49 patients; 14 (29%) had abnormal adrenergic function, and 15 (31%) had a cardiovagal abnormality. Electromyography and nerve conduction studies were performed in 24 (36%) of the 67 patients. Of these 24 patients, 14 (58%) had abnormal electromyographic results and 10 (42%) had abnormal nerve conduction study results. Vascular function studies, with and without symptoms present, were performed in 13 of the 67 patients. During symptoms, the mean temperature of the toe skin increased by 7.8°C, and blood flow increased 10.2-fold. Paradoxically, mean transcutaneous oximetry measurements did not change.

Conclusion  This prospective study extends and confirms our previous observation that, in addition to other forms of neuropathy, most patients with erythromelalgia have small-fiber neuropathy.

From the Departments of Dermatology (Dr Davis) and Neurology (Drs Sandroni and Low), and the Gonda Vascular Center (Dr Rooke), Mayo Clinic, Rochester, Minn. The authors have no relevant financial interest in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Neurovascular Instability Syndrome: A Unifying Term to Describe the Coexistence of Temperature-Related Vascular Disorders in Affected Patients
Rosalyn George, Gregory J. Fulchiero, Jr, James G. Marks, Jr, and Jennie T. Clarke
Arch Dermatol. 2007;143(2):274-275.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intervention for Erythromelalgia, a Chronic Pain Syndrome: Comprehensive Pain Rehabilitation Center, Mayo Clinic
Durosaro et al.
Arch Dermatol 2008;144:1578-1583.
ABSTRACT | FULL TEXT  

Neurovascular Instability Syndrome: A Unifying Term to Describe the Coexistence of Temperature-Related Vascular Disorders in Affected Patients
George et al.
Arch Dermatol 2007;143:274-275.
FULL TEXT  

Defining a Treatable Cause of Erythromelalgia: Acute Adolescent Autoimmune Small-Fiber Axonopathy
Paticoff et al.
Anesth. Analg. 2007;104:438-441.
ABSTRACT | FULL TEXT  

Sodium channels and pain
Benarroch
Neurology 2007;68:233-236.
FULL TEXT  

Thermoregulatory Sweat Testing in Patients With Erythromelalgia
Davis et al.
Arch Dermatol 2006;142:1583-1588.
ABSTRACT | FULL TEXT  

Erythromelalgia: An Underrecognized Manifestation of Small-Fiber Neuropathy
Kumar and Davis
Mayo Clin Proc. 2006;81:1001-1001.
FULL TEXT  

A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons
Rush et al.
Proc. Natl. Acad. Sci. USA 2006;103:8245-8250.
ABSTRACT | FULL TEXT  

Lidocaine Patch for Pain of Erythromelalgia: Follow-up of 34 Patients
Davis and Sandroni
Arch Dermatol 2005;141:1320-1321.
FULL TEXT  

Primary Erythromelalgia in a Child Responding to Intravenous Lidocaine and Oral Mexiletine Treatment
Nathan et al.
Pediatrics 2005;115:e504-e507.
ABSTRACT | FULL TEXT  

Erythromelalgia
Davis
Mayo Clin Proc. 2004;79:298-298.
 

Erythromelalgia -- Cutaneous Pain Syndrome or Vascular Abnormality?
Journal Watch Dermatology 2003;2003:4-4.
FULL TEXT